Literature DB >> 10823782

Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis.

L Bont1, A Kavelaars, C J Heijnen, A J van Vught, J L Kimpen.   

Abstract

The correlation of clinical and immunological parameters with the duration of respiratory failure was investigated to identify factors determining the clinical outcome of respiratory syncytial virus (RSV) bronchiolitis necessitating mechanical ventilation. At initiation of mechanical ventilation in 30 patients with RSV, production of interleukin (IL)-12 and IL-10 was measured in 48-h peripheral blood cell cultures that were stimulated with lipopolysaccharide and interferon-gamma. The ventilation index (VI)-an indicator of respiratory dysfunction that includes partial pressure of arterial CO2, peak airway pressure, and respiratory rate-correlated with the duration of mechanical ventilation (r=.47; P=.013). Age was not associated with the duration of mechanical ventilation. A highly significant inverse correlation was found between the duration of mechanical ventilation and the production of IL-12 at admission (r=-.62; P<.001). This correlation was independent of VI. No correlation was found between IL-10 production and the duration of mechanical ventilation. It is hypothesized that low monocyte IL-12 response during initial RSV infection adversely affects clinical outcome of patients with severe RSV bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823782     DOI: 10.1086/315433

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Development of interleukin-12-producing capacity throughout childhood.

Authors:  John W Upham; Peter T Lee; Barbara J Holt; Tricia Heaton; Susan L Prescott; Mary J Sharp; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.

Authors:  K K Tekkanat; H Maassab; A A Berlin; P M Lincoln; H L Evanoff; M H Kaplan; N W Lukacs
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Modulation of respiratory syncytial virus-induced prostaglandin E2 production by n-3 long-chain polyunsaturated fatty acids in human respiratory epithelium.

Authors:  Dani-Louise Bryan; Prue Hart; Kevin Forsyth; Robert Gibson
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

4.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

5.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

6.  Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  A Gagro; M Tominac; V Krsulović-Hresić; A Baće; M Matić; V Drazenović; G Mlinarić-Galinović; E Kosor; K Gotovac; I Bolanca; S Batinica; S Rabatić
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

Review 8.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

9.  Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncitial virus bronchiolitis.

Authors:  A Mandelberg; G Tal; L Naugolny; K Cesar; A Oron; S Houri; E Gilad; E Somekh
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells.

Authors:  H Bartz; F Büning-Pfaue; O Türkel; U Schauer
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.